The frequencies of the HLA-A, B, C, DR, DQ antigens and of several other genetic markers in biopsy proved and well characterised patients with Wegener's granulomatosis were compared with control frequencies of the region. A highly significant increase in HLA-DR1 was found. The percentage combined frequency of DRI-DQwl was significantly higher in patients than in the controls. Interestingly, association with the red cell enzyme GLOI and complement locus C4B was also seen. As both of these markers are either linked or within the major histocompatibility complex region (MHC) this is further evidence for the involvement of chromosome 6 in the pathogenesis of Wegener's granulomatosis. To understand the pathology of the disease fully molecular genetic studies of the MHC region are warranted.
Wegener's granulomatosis is a rare disease first described by Klinger in 19311 and subsequendy characterised by Wegener in 19362 and 1939.3 The diagnostic features of the disease consist of necrotising granulomata with vasculitis of the upper and lower respiratory tracts, systemic vasculitis, and focal necrotising glomerulitis. A limited form exists in which lesions morphologically identical to the above are localised to a single site.4 5 Less commonly, other nonclassical sites may also be affected and consequently the disease has protean manifestations.
The aetiological factors in the development of Wegener 
